ULIVI, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 3.543
NA - Nord America 1.476
EU - Europa 1.194
SA - Sud America 206
AF - Africa 124
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.550
Nazione #
US - Stati Uniti d'America 1.430
CN - Cina 1.030
SG - Singapore 980
VN - Vietnam 743
IT - Italia 291
HK - Hong Kong 271
DE - Germania 265
KR - Corea 223
BR - Brasile 145
NL - Olanda 142
FR - Francia 109
SE - Svezia 103
IN - India 98
GB - Regno Unito 79
JP - Giappone 56
FI - Finlandia 51
CI - Costa d'Avorio 50
IE - Irlanda 32
RU - Federazione Russa 30
AR - Argentina 28
ID - Indonesia 28
MX - Messico 21
PH - Filippine 21
SC - Seychelles 20
BG - Bulgaria 19
CA - Canada 18
BD - Bangladesh 15
AT - Austria 14
ZA - Sudafrica 14
TG - Togo 13
TH - Thailandia 13
JO - Giordania 12
UA - Ucraina 12
BE - Belgio 11
TR - Turchia 11
CO - Colombia 7
EC - Ecuador 7
PL - Polonia 7
CH - Svizzera 6
IQ - Iraq 6
MA - Marocco 6
TW - Taiwan 6
AU - Australia 5
PE - Perù 5
PY - Paraguay 5
UZ - Uzbekistan 5
KE - Kenya 4
LT - Lituania 4
ES - Italia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
LB - Libano 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
PK - Pakistan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 6.550
Città #
Singapore 754
Hefei 531
Hong Kong 261
Ashburn 235
San Jose 224
Seoul 217
Ho Chi Minh City 208
Hanoi 155
Amsterdam 73
Council Bluffs 73
Dallas 66
Los Angeles 59
Santa Clara 59
Fairfield 56
Beijing 55
Lauterbourg 54
Chandler 51
Abidjan 50
Bengaluru 47
Southend 45
Tokyo 45
Bologna 43
Krefeld 41
Dublin 32
Milan 31
Boardman 30
Dong Ket 28
Da Nang 26
Helsinki 26
Munich 26
Rome 26
Wilmington 26
Frankfurt am Main 25
Woodbridge 24
Princeton 23
Seattle 23
Jakarta 20
Ann Arbor 19
Sofia 19
Haiphong 18
Houston 18
The Dalles 18
Tongling 18
Lappeenranta 17
Redondo Beach 17
Buffalo 16
Chicago 16
Bad Bellingen 15
Guangzhou 15
New York 15
Cambridge 14
Lomé 13
Potenza 13
Amman 12
Biên Hòa 12
São Paulo 12
Hải Dương 11
Nuremberg 11
Can Tho 10
Falkenstein 10
Johannesburg 10
Mexico City 10
Shanghai 10
Turin 10
Vienna 10
Bắc Ninh 8
Düsseldorf 8
Orem 8
Turku 8
Berlin 7
Cesena 7
Delhi 7
Ha Long 7
Hillsboro 7
Montreal 7
Nanjing 7
Salt Lake City 7
Tianjin 7
Xi'an 7
Brussels 6
Jacksonville 6
London 6
Nha Trang 6
Paris 6
Quận Bình Thạnh 6
Redmond 6
Rimini 6
Rio de Janeiro 6
Stockholm 6
Baghdad 5
Denver 5
Elk Grove Village 5
Hangzhou 5
Jinan 5
Naples 5
Rancho Palos Verdes 5
San Diego 5
San Francisco 5
Tampa 5
Thái Nguyên 5
Totale 4.374
Nome #
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer 311
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 279
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 241
Schedule-dependent cytotoxic interaction between Epidoxorubicin and Gemcitabine in human bladder cancer cells in vitro. 233
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 194
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 178
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 169
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer 168
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 164
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 158
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 154
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 151
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 149
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 147
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation 147
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 145
Genetic and epigenetic alterations of cdh1 regulatory regions in hereditary and sporadic gastric cancer 145
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 143
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 143
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 136
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 136
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab 135
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 133
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer 133
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 133
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 129
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? 128
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 127
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 125
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities 123
Genomic events stratifying prognosis of early gastric cancer 122
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer 121
Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials. 117
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress 117
Moving beyond parp inhibition: Current state and future perspectives in breast cancer 116
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 111
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 109
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 108
Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis 108
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients 99
Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report. 90
The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration 90
New generation anaplastic lymphoma kinase inhibitors 77
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial 76
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer 68
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer 67
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer 59
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer 51
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA 46
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome 31
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study 25
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 24
Targeting RET-rearranged non-small-cell lung cancer: future prospects 16
Totale 6.705
Categoria #
all - tutte 15.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 2 22 54
2021/2022246 5 0 16 24 18 6 4 31 7 17 80 38
2022/2023283 17 42 17 27 18 27 4 21 63 4 22 21
2023/2024311 7 20 9 9 28 17 21 13 159 10 11 7
2024/20251.323 61 89 54 92 80 41 30 34 42 197 201 402
2025/20264.241 515 731 532 395 333 137 480 216 661 241 0 0
Totale 6.705